All eyes will be on the House today as we await a vote on "Trumpcare." If the bill is passed, expect the markets to soar, according to Money Morning Chief Investment Strategist Keith Fitz-Gerald. On the other hand, if it is not passed, expect the markets to drop.
The healthcare bill will have so much influence over the markets today because many associate the passage of the bill with the effectiveness of the Trump administration. So if it doesn't pass, many will question whether President Trump can get his infrastructure spending and tax cuts through Congress.
Now that we know what's moving markets, here are the three top stocks to watch today...
Top Stocks to Watch Today: Synergy Pharmaceuticals Inc. (Nasdaq: SGYP)
Synergy Pharmaceuticals stock is up 5% in early morning trading after an 8.6% drop in stock price yesterday.
Urgent: A completely unique gold play is forming in the markets. And it's so rare that it's only the third time in 20 years that it's happened. If you get in now, you could see a share of upwards of $13 billion in cash windfalls. Read more.
The company is a biopharmaceutical firm that specializes in the development and sale of gastrointestinal (GI) therapies. Currently, Synergy has two products in the pipeline. They are plecanatide and dolcanatide.
Synergy Pharmaceuticals stock currently has a "Strong Buy" rating, according to the six analysts that follow the company.
Analysts have a one-year price target of $11.50 for the company, which is a gain of 150% from its current trading price of $4.56.
SGYP stock is currently down 25% so far this year.
Top Stocks to Watch Today: PVH Corp. (NYSE: PVH)
PVH stock is up 7.5% in early morning trading after releasing its quarterly earnings report.
The company is a clothing corporation that owns brands such as Calvin Klein, Tommy Hilfiger, and Van Heusen.
Earnings per share (EPS) were $1.23, while analysts' expectations were $1.19. While the company's EPS was less than the $1.52 it posted for the same quarter last year, beating expectations has traders bullish.
Guidance for the year is for EPS of $7.30 to $7.40, which is better than the $6.80 EPS for the previous year.
PVH stock is trading at $90.85, which is a gain of 0.7% year to date (YTD). The one-year target price for the company is $109.53, which would be a gain of over 20%.
Top Stocks to Watch Today: Neurocrine Biosciences Inc. (Nasdaq: NBIX)
Neurocrine Biosciences stock is up 8.6% in early morning trading after announcing phase 3 results.
The company develops treatments for neurological and endocrine-based disorders and diseases.
Currently, Neurocrine has been working on a drug called Ingrezza, which treats tardive dyskinesia (a disorder with involuntary and repetitive body movements). The full phase 3 trial results were published in a journal paper ahead of the deadline for the FDA to approve the new drug.
Neurocrine Biosciences is hoping to beat out Teva Pharmaceutical Industries Ltd. (NYSE ADR: TEVA) for the treatment approval for tardive dyskinesia to win the first-mover advantage.
The FDA approval deadline for Ingrezza is Aug. 30.
NBIX stock is currently trading at $41.72 for a gain of 7.8% YTD.
Secret Weapon Set to Foil China's Master Plan: The South China Sea is about to get violent, and the Chinese have an alarming new superweapon they think gives them the upper hand. Or at least that's what their war hawks think. But they couldn't be more wrong. Thanks to a small $6 U.S. defense contractor with a top-secret technology, the Pentagon has an ingenious new checkmate move designed to stop a Chinese sneak attack dead in its tracks. Click here to learn more...